abstract |
The present invention relates to a combination of IL-10 and rapamycin capable of inducing immunosuppression and antigen-specific immune tolerance and its in the treatment of diseases involving T cells mediated enhancement, dysfunction or uncontrolled immune response Disclose the use. |